welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
withdrawn

Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis

key information

study id #: NCT00026468

condition: Colorectal Cancer, Small Intestine Cancer

status: withdrawn

purpose:

RATIONALE: Exisulind may be effective in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.

PURPOSE: Randomized phase II/III trial to determine the effectiveness of exisulind in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.

intervention: Drug: exisulind

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close